Medicamen Biotech Ltd - Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter And Half Year Ended On September 30, 2025

Download	< Back
05 Nov 2025
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2025.
View all announcements for Medicamen Biotech Ltd	Source: BSE India